FDA Action Alert: Theravance’s Approval, Mallinckrodt and Aquestive

The Food and Drug Administration (FDA) is taking care of a few approvals and committee meetings ahead of the Thanksgiving holiday week. They include drugs for chronic obstructive pulmonary disease, a pain drug, and a sublingual film formulation of a well-known drug for erectile dysfunction. Here’s a look. Theravance’s Revefenacin for COPD Theravance Biopharma, based in Dublin, … Συνεχίστε να διαβάζετε FDA Action Alert: Theravance’s Approval, Mallinckrodt and Aquestive.

FDA Approves Humira Biosimilar That Won’t Be Available Until 2023

FDA Approves Humira Biosimilar That Won’t Be Available Until 2023

Teva Snags FDA Approval for Generic EpiPen

Shares of Teva Pharmaceuticals jumped more than 7 percent in afternoon trading Thursday and continue to rise in premarket trading this morning after the U.S. Food and Drug Administration (FDA) approved the company’s generic version of the EpiPen Auto-Injector. This is the first generic version of the widely used EpiPen made by Mylan. The rising consumer cost of the branded EpiPen … Συνεχίστε να διαβάζετε Teva Snags FDA Approval for Generic EpiPen.